287 related articles for article (PubMed ID: 30954503)
1. Spatial intratumor heterogeneity in uveal melanoma: Tumor cell subtypes with a presumed invasive potential exhibit a particular epigenetic staining reaction.
Herwig-Carl MC; Sharma A; Höller T; Holz FG; Schlitter AM; Loeffler KU
Exp Eye Res; 2019 May; 182():175-181. PubMed ID: 30954503
[TBL] [Abstract][Full Text] [Related]
2. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
3. Role of Epigenetics in Uveal Melanoma.
Li Y; Jia R; Ge S
Int J Biol Sci; 2017; 13(4):426-433. PubMed ID: 28529451
[TBL] [Abstract][Full Text] [Related]
4. Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.
Herlihy N; Dogrusöz M; van Essen TH; Harbour JW; van der Velden PA; van Eggermond MC; Haasnoot GW; van den Elsen PJ; Jager MJ
Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1447-58. PubMed ID: 25593028
[TBL] [Abstract][Full Text] [Related]
5. Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study.
Herwig-Carl MC; Sharma A; Tischler V; Pelusi N; Loeffler KU; Holz FG; Zeschnigk M; Landreville S; Auw-Haedrich C; Noberini R; Bonaldi T
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):27. PubMed ID: 38349785
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
[TBL] [Abstract][Full Text] [Related]
7. DNA Methylation and Uveal Melanoma.
Yang ZK; Yang JY; Xu ZZ; Yu WH
Chin Med J (Engl); 2018 Apr; 131(7):845-851. PubMed ID: 29578129
[TBL] [Abstract][Full Text] [Related]
8. [Pathological and molecular genetic characteristics in patients with extrabulbar growth of uveal melanoma].
Saakyan SV; Khoroshilova-Maslova IP; Tsygankov АY; Amiryan АG; Isaeva RТ
Arkh Patol; 2016; 78(4):20-26. PubMed ID: 27600778
[TBL] [Abstract][Full Text] [Related]
9. EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.
Neumann LC; Weinhäusel A; Thomas S; Horsthemke B; Lohmann DR; Zeschnigk M
BMC Cancer; 2011 Aug; 11():380. PubMed ID: 21871071
[TBL] [Abstract][Full Text] [Related]
10. Multiplex ligation-dependent probe amplification analysis of uveal melanoma with extraocular extension demonstrates heterogeneity of gross chromosomal abnormalities.
Lake SL; Damato BE; Dopierala J; Baudo MM; Taktak AF; Coupland SE
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5559-64. PubMed ID: 21659309
[TBL] [Abstract][Full Text] [Related]
11. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
[TBL] [Abstract][Full Text] [Related]
12. Targeting Epigenetic Modifications in Uveal Melanoma.
Chokhachi Baradaran P; Kozovska Z; Furdova A; Smolkova B
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32726977
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide aberrant methylation in primary metastatic UM and their matched metastases.
Smit KN; Boers R; Vaarwater J; Boers J; Brands T; Mensink H; Verdijk RM; van IJcken WFJ; Gribnau J; de Klein A; Kilic E
Sci Rep; 2022 Jan; 12(1):42. PubMed ID: 34997020
[TBL] [Abstract][Full Text] [Related]
14. EPIGENETIC CHANGES IN MALIGNANT UVEAL MELANOMA AND POSSIBILITIES OF THEIR THERAPEUTIC TARGETING.
Smolková B; Demková L
Cesk Slov Oftalmol; 2020; 76(2):55-60. PubMed ID: 33126799
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma.
Venza M; Visalli M; Biondo C; Lentini M; Catalano T; Teti D; Venza I
Biochim Biophys Acta; 2015 Mar; 1849(3):247-56. PubMed ID: 25497382
[TBL] [Abstract][Full Text] [Related]
16. Role of epigenetic deregulation in hematogenous dissemination of malignant uveal melanoma.
Smolkova B; Horvathova Kajabova V; Zmetakova I; Kalinkova L; Czanner G; Markova A; Furdova A
Neoplasma; 2018 Nov; 65(6):840-854. PubMed ID: 30334454
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic insights into uveal melanoma.
Sharma A; Stei MM; Fröhlich H; Holz FG; Loeffler KU; Herwig-Carl MC
Clin Genet; 2018 May; 93(5):952-961. PubMed ID: 28902406
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
[TBL] [Abstract][Full Text] [Related]
20. Density of PAS positive patterns in uveal melanoma: Correlation with vasculogenic mimicry, gene expression class, BAP-1 expression, macrophage infiltration, and risk for metastasis.
Stålhammar G; See TRO; Phillips SS; Grossniklaus HE
Mol Vis; 2019; 25():502-516. PubMed ID: 31588174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
